Ireland
--:--IST
Recruiting Observational

Evaluation of Foreign Body Airway Obstruction Interventions Among Young Children: A Prospective Cohort Study

NCT07817693 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2026-05-01
Last updated
2026-09-14

Condition(s) studied

Choking

Study summary

Foreign body airway obstruction (FBAO, choking) is a life-threatening emergency requiring time-sensitive treatment to prevent severe injury or deaths. Traditional treatments taught in first aid courses include abdominal thrusts, back blows, and chest compressions or thrusts. Currently, first aid guidelines recommend different treatments for adults, child and infants. Until recently, data on these techniques was limited to case series from the late 1900's. To further improve our knowledge of which treatment is most effective and safest for patients, this study will collect data on choking incidents in Alberta, Canada. This study will focus on infants aged 2 years or younger.

Eligibility

Sex
ALL
Min age
—
Max age
2 Years
Healthy volunteers
No
Inclusion Criteria: * \- Young children (aged 2 years or less) who experienced an out-of-hospital FBAO in Alberta, Canada * Received a FBAO intervention by bystander or healthcare provider * Were assessed by EMS at the time of the incident, or later attended an emergency department due to the incident Exclusion Criteria: \- Patients with abnormal airway anatomy such as a tracheostomy.

Primary outcome measure(s)

  • Foreign body airway obstruction relief — Day 1
    Defined as: responders determining that the patient did not require further FBAO intervention due to improvement or resolution of their respiratory distress in a conscious patient, or the ability for a responder to successfully ventilate an unconscious patient when previously they were unable to due to obstruction

Trial sites (1)

FacilityCityRegionStatus
Virtual Calgary Alberta Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07817693 on ClinicalTrials.gov ↗ ← All trials in Canada